CompletedNot Applicable

Conventional Versus Modified Pre-surgical Naso-Alveolar Molding Treatment in Cleft Lip and Palate Infants

Egypt20 participantsStarted 2024-06-16

Plain-language summary

The aim of this study is to evaluate and compare clinically conventional Pre-surgical Naso-Alveolar Molding (PNAM) treatment versus Modified Naso-Alveolar Molding protocol (MPNAM) in cleft lip and palate patients in terms of: 1. Decreasing cleft gap. 2. Attaining columellar length. 3. Effect on maxillary growth. 4. Treatment Duration. 5. Parents acceptance.

Who can participate

Age range2 Weeks – 2 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The age range from 14 -30 days after birth.
✓. Has complete cleft lip and palate.
✓. Parents acceptance.
✓. Medically free infants.

Exclusion criteria

✕. Syndromic patients.
✕. Medically compromised patients contradicting operation.

What they're measuring

Attaining columellar length

Timeframe: 3 month

Trial details

NCT IDNCT06494098

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Cleft Lip and/or Palate trials